SALCLOBUZATE SODIUM

Details

Stereochemistry	ACHIRAL
Molecular Formula	C11H11ClNO4.Na
Molecular Weight	279.652
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].OC1=CC(Cl)=CC=C1C(=O)NCCCC([O-])=O

InChI

InChIKey=UQFYDAAKCZKDHS-UHFFFAOYSA-M

InChI=1S/C11H12ClNO4.Na/c12-7-3-4-8(9(14)6-7)11(17)13-5-1-2-10(15)16;/h3-4,6,14H,1-2,5H2,(H,13,17)(H,15,16);/q;+1/p-1

HIDE SMILES / InChI

Description
Sources: https://www.kegg.jp/dbget-bin/www_bget?dr:D08994

Salclobuzate sodium was developed as an oral absorption promoter. This compound had to “chaperone” poorly permeable payloads across the intestine. Information about the current use of this compound is not available.

Approval Year

PubMed

Title	Date	PubMed
Oral insulin.	2010-11-08	21059246
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes.	2010-06	20185734

Patents

Name

Type

Language

4-CNAB

Preferred Name

English

SALCLOBUZATE SODIUM

Official Name

English

SALCLOBUZATE SODIUM [USAN]

Common Name

English

Sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C2140